Jefferies Financial Group Stock News

The newspaper, citing people with knowledge of the matter, said the regulator is looking into whether Jefferies gave investors enough information on its Point Bonita fund's exposure to the failed auto business. The inquiry into internal controls and potential conflicts within the bank is at an early stage, the report said.

Canadian bank stocks look “fully valued” after a sharp autumn rally, leaving little room for disappointment as lenders prepare to report fourth-quarter results, Jefferies said on Tuesday as it downgraded Royal Bank of Canada (TSX:RY) and Toronto-Dominion Bank (TSX:TD) to ‘Hold.' The brokerage said credit trends should remain broadly stable, with flat Stage 1 and Stage 2 provisions and “likely i...

A U.S. bankruptcy judge on Wednesday ordered an independent investigation into auto parts maker First Brands, allocating a $7 million budget to probe allegations of fraud involving the company's use of third-party financing for customer invoices.

MORRISVILLE, N.C.--(BUSINESS WIRE)-- #JefferiesHealthcare--Presentation will focus on its flagship MRD assay, Pathlight, accompanied by a commercial update following its favorable Medicare coverage.

STOCKHOLM, SE / ACCESS Newswire / November 17, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today announced participation in the Jefferies Global Healthcare Conference in London: Location : London, UK Format : Presentation and 1×1 meetings Presentation Date and Time : Tuesday, November 18 ...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Christophe Douat, Chief Executive Officer, and Dr. Richard Malamut, Chief Medical Officer, will present Medincell's (Paris:MEDCL) corporate overview during a fireside chat at the Jefferies London Global Healthcare Conference on Tuesday, November 18, 2025, at 4:00 p.m. GMT (5:00 p.m. CET). Live webcast and replay: https://wsw.com/webcast/jef...

DUBLIN , Nov. 12, 2025 /PRNewswire/ -- Keenova Therapeutics plc ("Keenova" or the "Company") today announced that management will present at the Jefferies Global Healthcare Conference in London on Wednesday, November 19, 2025, at 10:00 a.m. Greenwich Mean Time (GMT) (5:00 a.m.

LONDON and CAMBRIDGE, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics' or ‘the Company'), a leading clinical-stage biotechnology company with a mission to save and restore vision in people with rare and prevalent ocular diseases, today announced that members of its management team will participate in the Jefferies Global Healthcare Conference ...